Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail Vikelis

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|July 14, 2023
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek RegistryMichail Vikelis, Emmanouil V Dermitzakis, Georgia Xiromerisiou, et al.
Neurology International|September 27, 2023
Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control StudyMaria Papasavva, Michail Vikelis, Vasileios Siokas, et al.
Toxins|June 25, 2026
Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study GroupAndreas A Argyriou, Emmanouil V Dermitzakis, Dimitrios Rikos, et al.
Frontiers in Neurology|March 5, 2025
Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensusGeorgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, et al.
Frontiers in Neurology|April 17, 2025
Corrigendum: Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensusGeorgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, et al.
The Journal of Headache and Pain|October 8, 2017
Patients' preferences for headache acute and preventive treatmentDimos D Mitsikostas, Ioanna Belesioti, Chryssa Arvaniti, et al.
Journal of Clinical Medicine|April 13, 2024
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic ReviewDimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, et al.
Frontiers in Neurology|February 4, 2026
Efficacy of single-dose galcanezumab 240 mg on episodic or refractory chronic cluster headache: prospective, 4-week, real-world evidence from the GRASP study groupMichail Vikelis, Andreas A Argyriou, Maria Chondrogianni, et al.
Journal of Clinical Medicine|December 30, 2020
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine ProphylaxisMichail Vikelis, Emmanouil V Dermitzakis, George S Vlachos, et al.
Toxins|November 26, 2025
OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study GroupAndreas A Argyriou, Emmanouil V Dermitzakis, Maria Chondrogianni, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|July 14, 2023
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek RegistryMichail Vikelis, Emmanouil V Dermitzakis, Georgia Xiromerisiou, et al.
Neurology International|September 27, 2023
Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control StudyMaria Papasavva, Michail Vikelis, Vasileios Siokas, et al.
Toxins|June 25, 2026
Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study GroupAndreas A Argyriou, Emmanouil V Dermitzakis, Dimitrios Rikos, et al.
Frontiers in Neurology|March 5, 2025
Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensusGeorgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, et al.
Frontiers in Neurology|April 17, 2025
Corrigendum: Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensusGeorgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, et al.
The Journal of Headache and Pain|October 8, 2017
Patients' preferences for headache acute and preventive treatmentDimos D Mitsikostas, Ioanna Belesioti, Chryssa Arvaniti, et al.
Journal of Clinical Medicine|April 13, 2024
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic ReviewDimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, et al.
Frontiers in Neurology|February 4, 2026
Efficacy of single-dose galcanezumab 240 mg on episodic or refractory chronic cluster headache: prospective, 4-week, real-world evidence from the GRASP study groupMichail Vikelis, Andreas A Argyriou, Maria Chondrogianni, et al.
Journal of Clinical Medicine|December 30, 2020
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine ProphylaxisMichail Vikelis, Emmanouil V Dermitzakis, George S Vlachos, et al.
Toxins|November 26, 2025
OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study GroupAndreas A Argyriou, Emmanouil V Dermitzakis, Maria Chondrogianni, et al.
Pageof 7